Outcomes for adults who had PANDAS as children range widely, from full recovery with no lasting effects to chronic neuropsychiatric symptoms that reshape daily life for years or even decades. A significant portion of patients do recover, particularly those who received early and effective treatment, but a meaningful subset carry persistent obsessive-compulsive symptoms, tics, anxiety, and emotional volatility well into adulthood. The trajectory depends on factors like the severity and frequency of childhood flares, how quickly the condition was recognized, and individual immune and genetic profiles. What makes this especially complicated is that the medical community is still catching up to the reality that PANDAS does not always end when childhood does.
Why Symptoms Can Linger Into Adulthood
The core problem in PANDAS involves the immune system mistakenly attacking parts of the brain, particularly the basal ganglia, a cluster of structures deep in the brain that help regulate movement, emotion, and habit-forming behaviors. Research has documented that these brain regions can sustain lasting changes. A review of the evidence found persistent abnormalities in the caudate nucleus and putamen, including volume enlargement and microstructural alterations consistent with ongoing basal ganglia involvement, along with autoantibodies targeting specific neurons in the striatum and signs of blood-brain barrier disruption in animal models.1PubMed Central. Persistence of Basal Ganglia Dysfunction in PANS/PANDAS: Review of the Evidence
Neuroimaging studies back this up. A study comparing brain scans of children with PANS (the broader category that includes PANDAS) to healthy controls found that all assessed brain regions showed increased diffusivity on MRI, a marker of tissue disruption. The deep gray matter, including the thalamus, basal ganglia, and amygdala, showed the most pronounced differences, which lined up with the hallmark symptoms of obsessions, compulsions, emotional dysregulation, and sleep disturbances.2PubMed Central. Association of Pediatric Acute-Onset Neuropsychiatric Syndrome With Microstructural Differences in Brain Regions Detected via Diffusion-Weighted Magnetic Resonance Imaging These are not temporary shifts that resolve once a strep infection clears. In some patients, the structural changes appear to persist, which helps explain why some adults who had PANDAS as children still experience neuropsychiatric symptoms years later.
Inflammatory markers add another piece to the puzzle. A study of pediatric patients with acute neuropsychiatric disorders found elevated levels of the inflammatory molecule IL-17 in both blood and cerebrospinal fluid, with particularly marked elevations in the PANDAS and PANS subgroup. Interestingly, IL-17 levels trended higher in post-pubertal children, raising questions about whether the inflammatory process intensifies or changes character around puberty rather than simply fading away.3European Journal of Paediatric Neurology. IL-17 in serum and cerebrospinal fluid of pediatric patients with acute neuropsychiatric disorders: Implications for PANDAS and PANS
What Daily Life Looks Like for Affected Young Adults
For those whose symptoms do persist, the impact on everyday functioning can be severe. A qualitative study interviewing young adults living with PANS/PANDAS found that participation in work, employment, or studies was strikingly low. Out of the participants, only one was studying (with an adapted course plan) and one was working part-time. Most described spending their time at home, largely on their own, living what they characterized as a confined and deprived existence far from the social and professional milestones their peers had reached.4PubMed Central. Young adults’ experiences of living with paediatric acute-onset neuropsychiatric syndrome. An interview study
One participant in that study put it plainly: “Though it has been 15 years since I got sick, my life has become more and more confined. You could say it is deprived in some way. I do very little. I very rarely get out of the door and I have no activities that I do.” That kind of progressive narrowing is not what most people expect from a childhood illness, and it underscores how PANDAS can function more like a chronic condition than an acute one for some patients. The social isolation is compounded by the fact that many of these adults feel misunderstood by both the medical system and the people around them, having spent years with a diagnosis that many clinicians still view skeptically.
It is worth noting that this study captured the experience of those still significantly affected. The young adults who fully recovered in childhood are, by definition, not showing up in studies of ongoing illness. So the picture from qualitative research skews toward the more severe end of the spectrum. But the fact that any meaningful number of adults remain this disabled by a condition that started in childhood is itself the point.
Flares and Triggers That Do Not Stop at Age Eighteen
One of the defining features of PANDAS is its episodic nature: symptoms surge in response to infections. For adults who still carry the underlying vulnerability, new infections can reignite symptoms that had been dormant or manageable. COVID-19 provided a large-scale natural experiment. A survey of youth with PANS/PANDAS found that among those who contracted COVID, about 43% experienced severe symptom flares and another 23% reported mild flares, while 30% had no change.5PubMed Central. Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS
The more revealing finding from that study was the difference between those who had recovered from PANS/PANDAS and those still managing it. Among children considered recovered, 92% had no symptom change after COVID infection, compared to only 25% of those still actively dealing with the condition. After vaccination, the gap was even starker: 100% of recovered children had no symptom change, versus 66% of those still managing symptoms.5PubMed Central. Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS This suggests that recovery, when it happens, is fairly robust, but that patients who remain symptomatic are vulnerable to immune triggers well beyond streptococcal bacteria. Any significant immune challenge, whether a viral infection, a bacterial illness, or even physiological stress, can potentially set off a flare.
For adults who had PANDAS as children and still experience periodic worsening, this means that infection prevention is not just about general health. It is a neuropsychiatric management strategy. Avoiding untreated strep, staying current on vaccinations when appropriate, and recognizing early signs of an immune-triggered flare are all practical considerations that these adults and their doctors need to keep in mind.
The Naming Problem and Whether Adults Can “Have” PANDAS
The “P” in PANDAS stands for “pediatric,” which has created an awkward situation: the diagnostic label itself implies the condition belongs to childhood. When someone turns eighteen, their symptoms do not magically resolve, but the name suggests the condition should have ended. This has real consequences. Adults who present with what looks like ongoing PANDAS often struggle to find clinicians who will evaluate or treat them under that framework, since the diagnostic criteria were written for children.
A case report published in 2023 described a young adult with PANDAS whose illness proved fatal, representing the first description of neuropathological findings at autopsy for PANDAS or PANS. The authors noted that as recognition of adults suffering from this disorder grows, changing the nomenclature should be considered.6PubMed Central. Clinicopathologic Characteristics of PANDAS in a Young Adult: A Case Report That single case carries weight not because one death defines the condition, but because it demonstrated through direct tissue examination that the autoimmune brain inflammation seen in PANDAS does not respect age boundaries.
The broader diagnostic category of PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) was introduced partly to address the limitation of tying the diagnosis exclusively to strep infections, since other infections and immune triggers can cause similar presentations. But “pediatric” is still right there in the name. Some researchers and clinicians have started informally using terms like “adult-onset PANS” or simply describing the underlying autoimmune encephalitis, but there is no universally accepted adult diagnostic framework yet. This gap means adults who had PANDAS as children and still have symptoms often fall between specialties, bouncing between psychiatrists who treat their OCD or anxiety as primary psychiatric disorders and immunologists or neurologists who may not be familiar with the condition.
How Childhood Treatment Shapes Long-Term Outcomes
Early and aggressive treatment appears to improve the odds of a good long-term outcome, though the evidence base is still thin compared to many other conditions. The two main treatment strategies during childhood are antimicrobial approaches (treating and preventing strep infections) and immunomodulatory therapies (calming the immune attack on the brain).
On the antimicrobial side, the evidence for long-term antibiotic prophylaxis to prevent flares is mixed. One trial found that penicillin prophylaxis reduced neither strep infections nor neuropsychiatric symptoms, while a second trial found that penicillin or azithromycin given for one year reduced strep infections by about 95% and neuropsychiatric flares by 56-75%.7PubMed Central. Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part III—Treatment and Prevention of Infections The contradictory results mean clinicians lack a clear consensus on whether prophylactic antibiotics should be standard practice for PANDAS, let alone for how long. In practice, many families and doctors use a trial-and-error approach, continuing prophylaxis when it seems to help and stopping when it does not.
Intravenous immunoglobulin (IVIG), which works by broadly modulating the immune system, has shown short-term benefits in case reports. A case series of twelve youths treated with IVIG for PANDAS documented short-term symptom improvement and provided some of the first descriptions of long-term outcomes for PANDAS patients.8PubMed Central. Use of intravenous immunoglobulin in the treatment of twelve youths with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections IVIG is expensive, not universally available, and carries its own risks, so it tends to be reserved for moderate to severe cases. But for children who respond well, the treatment appears to meaningfully change their trajectory. The frustration is that large-scale randomized trials of IVIG for PANDAS are still lacking, so treatment decisions rely heavily on clinical judgment and small studies.
What this means for adults looking back on their childhood PANDAS is that the treatment they did or did not receive likely shaped where they ended up. Adults who were diagnosed early, had their strep infections treated promptly, and received immune-targeted therapy during acute flares seem to be the ones most likely to have recovered. Those who went years without a correct diagnosis, or who were treated only with psychiatric medications that addressed symptoms without touching the underlying immune process, are more likely to be among those still struggling.
The Connection Between Childhood Strep and Adult OCD
One of the more interesting research threads concerns whether childhood streptococcal infections leave a lasting footprint in adults diagnosed with OCD. A study of 247 adult OCD outpatients found that about one in five had elevated antistreptolysin O (ASO) titers, a marker of past or ongoing strep immune response. Among those with positive titers, patients taking OCD medication had significantly lower titers than those who were not medicated, and neutrophil counts were positively related to the distress associated with obsessive thoughts.9CNS Spectrums. The role of previous streptococcal infections in adult patients with obsessive-compulsive disorder: a research study
This does not prove that those adults had PANDAS as children. ASO titers can be elevated for many reasons, and strep infections are extremely common in childhood. But the correlation between immune markers of strep exposure and the severity of obsessive symptoms in adults is suggestive. It raises the possibility that some fraction of adult OCD, perhaps a small but meaningful fraction, has autoimmune roots tied to childhood strep exposure. If that is the case, some adults struggling with treatment-resistant OCD might benefit from immune-focused evaluations rather than continuing to escalate psychiatric medications alone.
The diagnostic overlap between PANDAS and garden-variety OCD is one of the most contentious issues in the field. Case reports have highlighted the difficulty of distinguishing between the two, particularly when a patient presents with OCD symptoms and a complicated medical history. One clinical case study emphasized the lack of diagnostic clarity in presentations where OCD and PANDAS features coexist, noting that the broader literature has struggled to define a clear neuropsychological profile that reliably separates PANDAS from other forms of OCD.10Oxford Academic. A-086 When to Consider Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus (PANDAS) in Ambiguous Obsessive–Compulsive Disorder (OCD) Presentation For an adult who had PANDAS as a child, this ambiguity can be deeply frustrating. They may know their symptoms started abruptly after a strep infection, but their current psychiatrist may view the OCD as a standalone condition with no relevant immunological history.
Genetic Vulnerability and Why Some Families See It Recur
PANDAS tends to cluster in families, and genomic research is beginning to explain why. A study using exome and whole-genome sequencing on PANS patients identified ultra-rare genetic variants, many in genes related to immune function and neuronal signaling. But the genetics are not deterministic. Several families in the study showed transmission from a carrier parent who did not have PANS, though those parents often had other immune-related conditions like asthma, allergies, or autoimmune disorders.11PubMed Central. Identification of ultra-rare genetic variants in pediatric acute onset neuropsychiatric syndrome (PANS) by exome and whole genome sequencing
Even identical twins do not always share the condition. The same study noted that monozygotic twin concordance in PANS shows a range of different outcomes, including complete discordance, where one twin develops the syndrome and the other does not. This pattern is consistent with autoimmune diseases generally, where twin concordance rates range from roughly 20% to 70% depending on the specific condition. The implication is that having the genetic vulnerability is necessary but not sufficient; environmental triggers, likely including the timing and severity of infections, play a decisive role in whether the syndrome actually manifests.11PubMed Central. Identification of ultra-rare genetic variants in pediatric acute onset neuropsychiatric syndrome (PANS) by exome and whole genome sequencing
For adults who had PANDAS and are now having children of their own, this creates a practical concern. The condition is not inherited in a simple, predictable pattern, but the family history of autoimmune sensitivity is real. Being aware of it means being alert to sudden-onset behavioral changes in your children after infections, which is exactly the kind of early recognition that gives the next generation a better shot at prompt treatment and a more complete recovery.
What Clinicians Still Get Wrong
Perhaps the biggest obstacle for adults who had PANDAS as children is the medical community’s uneven relationship with the diagnosis. PANDAS was first described in 1998, and for years it was treated as a hypothesis rather than an established condition. Even now, many clinicians trained outside specialized centers have limited familiarity with the diagnosis. Adults reporting a childhood history of PANDAS may encounter skepticism, particularly from providers who view the condition as overdiagnosed or who are unfamiliar with the evidence for its persistence.
The antibody picture itself adds to the confusion. One study found that standard ELISA-based measurements of anti-basal ganglia antibodies did not reliably differentiate PANDAS patients from controls, even though more targeted analysis of specific protein fractions did reveal differences, particularly in patients with prominent tics.12Movement Disorders. Anti-basal ganglia antibodies in PANDAS The practical upshot is that a routine blood test cannot definitively confirm or rule out the condition. Diagnosis still rests heavily on clinical history, particularly the hallmark pattern of abrupt symptom onset temporally linked to strep infection. For an adult recounting events from fifteen or twenty years ago, that history can be difficult to reconstruct with the specificity clinicians want.
Adults in this situation often find themselves becoming their own advocates, assembling childhood medical records, tracking patterns of symptom flares, and seeking out the small number of specialists who treat post-infectious autoimmune neuropsychiatric conditions in adults. Online patient communities have become critical lifelines, connecting people who share similar histories and helping them find knowledgeable providers. The science is moving in the right direction, with growing recognition that these conditions persist beyond childhood and that the immune and neurological underpinnings are real and measurable. But the gap between the research frontier and the average doctor’s office remains wide, and closing it is the single change that would most improve life for adults still affected by what started as a childhood illness.